최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한방비만학회지 = Journal of Korean Medicine for Obesity Research, v.22 no.2, 2022년, pp.136 - 146
박민정 (누베베 한의원 강남점) , 김은주 (누베베 미병연구소) , 옥지명 (누베베 한의원 강남점) , 최가혜 (누베베 한의원 홍대점) , 임영우 (누베베 미병연구소)
Objectives: The objective of this study is to evaluate weight change and analyze adverse events in overweight and obese women with polycystic ovary syndrome (PCOS) who were prescribed with Gamitaeeumjowee-tang. Methods: A retrospective chart review was conducted for medical records of patients with ...
Min WG. Polycystic ovary syndrome. J Korean Obstet?Gynecol. 2008 ; 51(8) : 805-19.
Korean Society of Obstetrics and Gynecology. Gynecology.?5th ed. Seoul : Korea Medical Book Publishing Company (KOMB). 2015 : 488.
Byun EG, Kim HJ, Oh JY, Hong YS, Sung YA. The?prevalence of polycystic ovary syndrome in college students?from Seoul. Journal of Korean Endocrine Society. 2005 ; 20(2) : 120-6.
Health Insurance Review & Assessment Service. Healthcare?Bigdata Hub [Internet]. 2022 [cited 2022 Oct 26]. Available?from: https://opendata.hira.or.kr/op/opc/olap4thDsInfo.do.
Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular?disease in women with polycystic ovary syndrome at?long-term follow-up: a retrospective cohort study. Clin?Endocrinol (Oxf). 2000 ; 52 : 595-600.
Kim JJ, Hwang KR, Choi YM, Moon SY, Chae SJ, Park?CW, et al. Complete phenotypic and metabolic profiles?of a large consecutive cohort of untreated Korean women?with polycystic ovary syndrome. Fertil Steril. 2014 ; 101(5) : 1424-30.
Thmas MB, Petra H, Martin OW, Stephen F. Obestiy?and polycystic overy syndrome: implications for pathogenesis?and novel management strategies. Clin Med Insights?Reprod Health. 2019 ; 13 : 1179558119874042.
Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored?insulin sensitivity but persistently increased early insulin?secretion after weight loss in obese women with polycystic?ovary syndrome. J Clin Endocrinol Metab. 1995 ; 80 : 2586-93.
Moran L, Norman RJ. Understanding and managing?disturbances in insulin metabolism and body weight in?women with polycystic ovary syndrome. Best Pract Res?Clin Obstet Gynaecol. 2004 ; 18(5) : 719-36.
Mamaru AA, Arul E, Anju EJ, Allison MH, Helena JT,?Wendy JB, et al. Weight gain and lifestyle factors in?women with and without polycystic ovary syndrome.?Human Reproduction. 2022 ; 37(1) : 129-41.
Linden HA, Naessen S, Stridsberg M, Bystrom B, Holte?J. Impaired cholecystokinin secretion and disturbed appetite?regulation in women with polycystic ovary syndrome.?Gynecol Endocrinol. 2004 ; 19 : 79-87.
Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias?K, Adonakis G, Decavalas G, et al. Basal metabolic?rate is decreased in womenwith polycystic ovary syndrome?and biochemical hyperandrogenemia and is associated?with insulin resistance. Fertil Steril. 2009 ; 92 : 250-5.
Robinson S, Chan SP, Spacey S, Anyaoku V, Johnston?DG, Franks S. Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased?insulin resistance. Clin Endocrinol. 1992 ; 36 : 537-43.
Hellas C, Luca C, Rossella EN. Obesity, polycystic ovary?syndrome, and infertility: a new avenue for GLP-1?receptor agonists. J Clin Endotrinl Metab. 2020 ; 105(8) : e2695-709.
Cho YJ, Lee YJ, Ahn YT, Kang ES, Kim HJ, Hong?DH, et al. A review of the clinical study trends on?Korean medicine treatment for polycystic ovary syndrome.?J Korean Obstet Gynecol. 2022 ; 35(2) : 87-105.
Park SH, Lee JM, Lee CH, Jang JB, Hwang DS. Analysis?of the characteristics and treatment of polycystic ovary?syndrome patients in a Korean medicine hospital. J?Korean Obstet Gynecol. 2019 ; 32(1) : 37-47.
Kim DH. A case study on obese patient with oligomenorrhea?and polycystic ovary. J Korean Med Obes Res. 2008 ; 8(1) : 101-8.
Lee JS. A case study on infertility with obesity and polycystic?ovary. J Korean Med Obes Res. 2005 ; 5(1) : 157-63.
Korea Institute of Drug Safety & Risk Reaction Management.?Adverse Drug Assessment Report. 1st ed. Seoul : Korea?Institute of Drug Safety & Risk Management. 2013 : 60-3.
National Cancer Institute, National Institute of Health,?U.S. Department of Health and Human Services. Common?Terminology Criteria for Adverse Events (CTCAE) Version?4.0 [Internet]. 2009 [cited 2009 May 29]. Available from:?https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf.
Korea Institute of Drug Safety & Risk Management.?Terminology guide for reporting adverse drug reactions.?Seoul : Korea Institute of Drug Safety & Risk Management. 2014 : 1-6.
Legro RS, Dodson WC, Kris-Etherton PM, Kunselman?AR, Stetter CM, Williams NI, et al. Randomized controlled?trial of preconception interventions in infertile?women with polycystic ovary syndrome. J Clin Endocrinol?Metab. 2015 ; 100 : 4048-58.
European Society of Human Reproduction and Embryology;?The Thessaloniki, and ASRM-Sponsored PCOS Consensus?Workshop Group. Consensus on infertility treatment related?to polycystic ovary syndrome. Hum Reprod. 2008 ; 23 : 462-77.
Dapas M, Lin FTJ, Nadkarni GN, Sick R, Legro RS,?Urbanek M, et al. Distinct subtypes of polycystic ovary?syndrome with novel genetic associations: an unsupervised,?phenotypic clustering analysis. PLoS Med. 2020 ; 17(6) : e1003132.
Kang EY, Park YJ, Kim MJ, Park YB. A study on factors?associated with weight loss by 'Gamitaeeumjowee-tang'.?J Korean Med Obes Res. 2017 ; 17(2) : 68-72.
Lee A, Lee DY, Kim MJ, Lee HS, Choi KH, Kim SY,?et al. Gamitaeeumjowee-tang for weight loss in diabetic?patients: a retrospective chart review. J Korean Med. 2021 ; 42(1) : 46-57.
Yoon NR, Yoo YJ, Kim MJ, Kim SY, Lim YW, Lim?HH, et al. Analysis of adverse events in weight loss program?in combination with 'Gamitaeeumjowee-tang' and?low-calorie diet. J Korean Med Obes Res. 2018 ; 18(1) : 1-9.
Park YJ, Cominguez DC, Kim HJ, Jin JS, Koh DJ, Kim?SY, et al. Therapeutic effects of Gambi-jung for the?treatment of obesity. Biomedicine & Pharmacotherapy. 2021; 141 : 111838.
Javed Z, Papageorgiou M, Dexhmukh H, Rigby AS, Qamar?U, Abbas J, et al. Effects of empagliflozin on metabolic?parameters in polycystic ovary syndrome: a randomized?controlled study. Clin Endocrinol (Oxf). 2019 ; 90(6) : 805-13.
Ma RL, Deng Y, Wang YF, Zhu SY, Ding XS, Sun AJ.?Short-term combined treatment with exenatide and metformin?for overweight/obese women with polycystic ovary?syndrome. Chin Med J (Engl). 2021 ; 134(23) : 2882-9.
Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A,?Fallahzadeh H, Nadjaradeh A. Effects of dietary approach?to stop hypertension diet on androgens, antioxidant?status and body composition in overweight and?obese women with polycystic ovary syndrome: a randomised?controlled trial. J Hum Nutr Diet. 2017 ; 30(3) : 275-83.
Jo GW, Ok JM, Kim SY, Lim YW. Review on the efficacy?and safety of Mahuang and ephedrine in the treatment?of obesity-focused on RCT. J Korean Med. 2017 ; 38(3) : 170-84.
Christensen P, Bliddal H, Riecke BF, Leeds AR, Astrup?A, Christensen R. Comparison of a low-energy diet and?a very low-energy diet in sedentary obese individuals:?a pragmatic randomized controlled trial. Obes. 2011 ; 1(1) : 31-40.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.